Author Question: The product life cycle theory predicts that comparative advantage shifts away from the country of ... (Read 44 times)

cdr_15

  • Hero Member
  • *****
  • Posts: 546
The product life cycle theory predicts that comparative advantage shifts away from the country of origin if:
 a. the product is introduced in many countries simultaneously.
  b. the product is highly demanded in international markets.
  c. the demand for the product drastically declines in the domestic market of the country where it was invented.
  d. other countries have lower manufacturing costs using the now-standardized technology.
  e. other countries develop highly skilled labor forces to improve product quality.

Question 2

Public goods, like national defense, are usually funded through government because:
 a. no one cares about them, because they are public.
 b. it is prohibitively difficult to withhold national defense from someone unwilling to pay for it.
  c. they cost too much for private firms to produce them.
 d. they provide benefits only to individuals, and not firms.



Hdosisshsbshs

  • Sr. Member
  • ****
  • Posts: 315
Answer to Question 1

d

Answer to Question 2

b



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

Though the United States has largely rejected the metric system, it is used for currency, as in 100 pennies = 1 dollar. Previously, the British currency system was used, with measurements such as 12 pence to the shilling, and 20 shillings to the pound.

Did you know?

Patients who have undergone chemotherapy for the treatment of cancer often complain of a lack of mental focus; memory loss; and a general diminution in abilities such as multitasking, attention span, and general mental agility.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library